Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 37051-37100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06016764
Use of MRI and CTBS for Catatonia in Autism
PHASE1Recruiting
40 participants
Started: Aug 23, 2023 · Completed: Aug 23, 2026
3 conditions2 sponsors1 location
NCT05978102
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
183 participants
Started: Aug 23, 2023 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06305195
Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome
N/ARecruiting
155 participants
Started: Aug 23, 2023 · Completed: Oct 21, 2026
1 condition1 sponsor1 location
NCT05439200
Video Treatment for Amblyopia
NARecruiting
44 participants
Started: Aug 23, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06549413
18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer
N/ARecruiting
60 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06592859
Quzhou Population Cohort Research Project (Aging Related Research: Intervention of Nicotinamide Mononucleotide in Middle-aged and Elderly People)
NARecruiting
240 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT05940038
Retrospective Study of the Safety and Efficacy of PLLA for Skin Flaccidity in Labia Majora and/or Pubis Region
N/ARecruiting
10 participants
Started: Aug 23, 2023 · Completed: Nov 30, 2023
1 condition1 sponsor1 location
NCT05283421
Improving Diagnostics in Cervical Dysplasia
NARecruiting
150 participants
Started: Aug 23, 2023 · Completed: Jul 16, 2025
1 condition1 sponsor1 location
NCT05811936
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
NARecruiting
352 participants
Started: Aug 23, 2023 · Completed: May 31, 2026
4 conditions3 sponsors1 location
NCT05969860
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
PHASE2Recruiting
200 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2025
43 conditions1 sponsor2 locations
NCT06259071
MuSK Myasthenia 1000 Study
N/ARecruiting
1,000 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05960591
Usability of the ADEPTH Sensor for Bore Depth Measurements in Plate Osteosynthesis Procedures
NARecruiting
60 participants
Started: Aug 23, 2023 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05152134
Mobile & Online-Based Interventions to Lessen Pain
PHASE3Recruiting
220 participants
Started: Aug 23, 2023 · Completed: May 1, 2026
3 conditions2 sponsors1 location
NCT06554041
Soft Tissue Response to Different Restorative Materials Used in Implant Dentistry
NARecruiting
40 participants
Started: Aug 23, 2023 · Completed: Jan 1, 2026
5 conditions1 sponsor1 location
NCT06032364
Stone Disease of the Urinary Tract in Children
N/ARecruiting
140 participants
Started: Aug 23, 2023 · Completed: Jun 23, 2025
1 condition1 sponsor1 location
NCT05758246
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
PHASE2Recruiting
220 participants
Started: Aug 23, 2023 · Completed: Aug 23, 2026
3 conditions1 sponsor10 locations
NCT05998278
Personalized Optimization of Systematic Prostate Biopsy
NARecruiting
664 participants
Started: Aug 23, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05897385
Analgesic Effect of IntraPeritoneal LIGNOcaine in Gynaecological Open Surgery
NARecruiting
112 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05810467
The Active Surveillance Study
N/ARecruiting
200 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05878860
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
PHASE1/PHASE2Recruiting
21 participants
Started: Aug 22, 2023 · Completed: Oct 31, 2029
1 condition1 sponsor4 locations
NCT05889624
Responding With Evidence and Access for Childhood Headaches
NARecruiting
400 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2027
8 conditions2 sponsors14 locations
NCT05360277
Maintenance Tislelizumab + Capecitabine to Treat Metastatic Colorectal Cancer
PHASE2Recruiting
52 participants
Started: Aug 22, 2023 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05697159
7 Tesla MRI Brain Imaging to Decipher Filgotinib's Mode of Analgesic Action in Rheumatoid Arthritis
N/ARecruiting
20 participants
Started: Aug 22, 2023 · Completed: Oct 31, 2025
5 conditions2 sponsors1 location
NCT00200889
Mapping Auricular Vagus Nerve Circuitry
EARLY_PHASE1Recruiting
50 participants
Started: Aug 22, 2023 · Completed: Jun 30, 2028
1 condition2 sponsors1 location
NCT05901545
Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer
PHASE1Recruiting
30 participants
Started: Aug 22, 2023 · Completed: Nov 30, 2029
2 conditions2 sponsors1 location
NCT06895980
Effect of Periodontal Treatment on Metabolic Control in Patients with Type-2 Diabetes Mellitus Treated in the Cardiovascular Healt Program
NARecruiting
80 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT05947669
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
PHASE3Recruiting
195 participants
Started: Aug 22, 2023 · Completed: Sep 30, 2028
1 condition3 sponsors3 locations
NCT06975618
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)
PHASE1/PHASE2Recruiting
141 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2029
2 conditions1 sponsor4 locations
NCT06017258
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
PHASE1Recruiting
15 participants
Started: Aug 22, 2023 · Completed: Aug 22, 2026
5 conditions1 sponsor7 locations
NCT06829095
Personalized Nutrition Counseling and Nutritional Status of Esophageal Cancer and HNSCC Patients Undergoing CCRT
N/ARecruiting
90 participants
Started: Aug 22, 2023 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT06314672
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
NARecruiting
208 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT05913882
Combined Respiratory Training in Persons with ALS
NARecruiting
34 participants
Started: Aug 22, 2023 · Completed: Sep 30, 2026
3 conditions2 sponsors1 location
NCT05896579
Identifying Right Ventricular Dysfunction in COPD Through Right Heart Catheterization, Imaging and Exercise
NARecruiting
36 participants
Started: Aug 22, 2023 · Completed: Jul 31, 2030
3 conditions1 sponsor1 location
NCT05016219
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients
NARecruiting
120 participants
Started: Aug 22, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor2 locations
NCT06039631
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
PHASE2Recruiting
82 participants
Started: Aug 22, 2023 · Completed: Sep 1, 2029
2 conditions6 sponsors1 location
NCT06086366
Presynaptic Imaging in Major Depressive Episodes After COVID-19
N/ARecruiting
90 participants
Started: Aug 22, 2023 · Completed: Sep 10, 2025
3 conditions1 sponsor1 location
NCT06030570
Effect of an Interdisciplinary Spine Rehabilitation Program
N/ARecruiting
90 participants
Started: Aug 22, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05995964
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
PHASE2Recruiting
340 participants
Started: Aug 22, 2023 · Completed: Dec 14, 2026
1 condition1 sponsor95 locations
NCT05809752
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)
PHASE1Recruiting
18 participants
Started: Aug 22, 2023 · Completed: Mar 31, 2026
3 conditions2 sponsors3 locations
NCT05492903
COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)
NARecruiting
140 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT05737693
Enhancing Week-long Psychological Treatment for PTSD With Ketamine
PHASE2Recruiting
162 participants
Started: Aug 21, 2023 · Completed: Aug 1, 2031
1 condition2 sponsors2 locations
NCT05757609
Transcranial Stimulation for Physiotherapy Optimisation - Chronic Low Back Pain (STOP-CLBP)
NARecruiting
48 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05618353
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
PHASE4Recruiting
700 participants
Started: Aug 21, 2023 · Completed: Apr 30, 2029
1 condition2 sponsors6 locations
NCT05928767
Evaluation of the Clinical Frailty Scale (CFS) as a Risk Factor of Mortality in Adult Patients ≤65 Years of Age Admitted to Intensive Care for Septic Shock.
N/ARecruiting
200 participants
Started: Aug 21, 2023 · Completed: Dec 1, 2025
2 conditions2 sponsors4 locations
NCT06237439
Sharing HaRT in New Expanses
NARecruiting
302 participants
Started: Aug 21, 2023 · Completed: May 31, 2025
3 conditions2 sponsors1 location
NCT05873244
CXD101 in Immunotherapy-related Liver Cancer
PHASE2Recruiting
44 participants
Started: Aug 21, 2023 · Completed: Dec 30, 2027
1 condition1 sponsor2 locations
NCT05597345
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
PHASE2Recruiting
15 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05975671
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
NARecruiting
52,500 participants
Started: Aug 21, 2023 · Completed: May 31, 2026
7 conditions6 sponsors4 locations
NCT05746884
Haemostatic Gel Prophylaxis for Post Duodenal Endoscopic Resection Bleeding
NARecruiting
234 participants
Started: Aug 21, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05999630
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated with Radioactive Iodine for Thyroid Cancer
PHASE3Recruiting
100 participants
Started: Aug 21, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location